The trial is testing whether Mavenclad could benefit upper limb movement in MS patients More: 100th patient joins ChariotMS trial for multiple sclerosis Source: News
read moreWeight loss Zepbound: Eli Lilly’s new obesity drug name tests well as it follows Novo’s Ozempic-Wegovy branding separation badams Fri, 11/10/2023 – 03:58 More: Weight loss Zepbound: Eli Lilly's new obesity drug name tests well as it follows Novo's Ozempic-Wegovy
read moreFierce Pharma Asia—AstraZeneca’s GLP-1 play; Takeda’s cancer drug approval; BioNTech’s bispecific deal aliu Fri, 11/10/2023 – 00:05 More: Fierce Pharma Asia—AstraZeneca's GLP-1 play; Takeda's cancer drug approval; BioNTech's bispecific deal Source: fierce
read moreTakeda scores second FDA approval this week with green light for rare blood clotting disorder drug Adzynma fkansteiner Thu, 11/09/2023 – 15:27 More: Takeda scores second FDA approval this week with green light for rare blood clotting disorder drug Adzynma
read moreCancer drugs buttress AstraZeneca as questions swirl around new indications aliu Thu, 11/09/2023 – 11:40 More: Cancer drugs buttress AstraZeneca as questions swirl around new indications Source: fierce
read moreAstraZeneca chases another liver cancer nod for Imfinzi with early phase 3 win, scraps Imfinzi-Lynparza combo study in lung cancer zbecker Thu, 11/09/2023 – 11:02 More: AstraZeneca chases another liver cancer nod for Imfinzi with early phase 3 win, scraps
read more© 1994 - 2026 B.M. Pharmaceuticals